三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
AK104与Volrustomig的安全性比较(NSCLC)
AK104与Volrustomig的安全性比较(NSCLC)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:126KB
图片尺寸:2280*660
同报告图片
/
4
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
5aW955qE77yM5Lul5LiL5piv5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOmAguW6lOeXhyB8IOmdnumznk5TQ0xDIHwg6bOe54q2TlNDTEMgfCDnu5Pnm7TogqDnmYwgfCDlpLTpoojnmYwgfCDog4bpgZPnmYwgfCBUTkJDIHwg6IOw6IW655mMIHwg6IOD55mMIHwg5bC/6Lev5LiK55qu55mMIHwg6aOf566h55mMIHwg5a6r6aKI55mMIHwg6IKd55mMIHwg5Y215bei55mMIHwg5a2Q5a6r5YaF6Iac55mMIHwg6IK+55mMIHwg6buR6Imy57Sg55ikIHwg6buY5YWL5bCU57uG6IOe55mMIHwgVE5CLUggfCDnmq7ogqTps57nirbnu4bog57nmYwgfCBNU0ktSC9kTU1SIHwg57uP5YW45Z6L6ZyN5aWH6YeR5reL5be055ikIHwKfC0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS18LS0tLS0tLS18LS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAyNeW5tEJsb29tYmVyZ+S4gOiHtOmihOacnyB8IDEzMCAgICAgICAgfCAgICAgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAyMy4zIHwgICAgICAgICAgICB8ICAgICAgICB8IDEwLjggICB8ICAgICAgfCAgICAgICAgfCAgICAgICAgICAgIHwgICAgICB8ICAgICAgICB8IDI0LjMgICAgICAgICAgIHwgMjEuNyAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICB8IDEyICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgS+iNr+mUgOWUrumine+8iOS6v+e+juWFg++8iSB8ICAgICAgICAgICAgfCAgICAgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgfCAgICAgICB8ICAgICAgIHwgICAgICAgfCAgICAgICAgICAgIHwgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgQ1BTPDHkurrnvqTljaDmr5TvvIgl77yJIHwgNDglICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgICB8IDE1JSAgICB8ICAgICAgICB8IDwxMCAgIHwgNjIlICB8ICAgICAgICAgICAgfCAgICAgICAgfCA8MTAgICAgfCA3Ny41JSB8ICAgICAgIHwgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfAp8IOWQhOWMuuWfn+aWsOWPkeS6uuaVsO+8iDIwMjTlubTvvIkgfCAgICAgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgIHwgICAgICAgfCAgICAgICB8ICAgICAgIHwgICAgICAgICAgICB8ICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfAp8IOS4reWbve+8iOS4h+S6uu+8iSB8IDY4LjAgICAgICAgfCAyOS4yICAgICAgIHwgNTguMCAgICAgfCAxNC4yICAgfCAyLjkgICAgfCA2LjYgICB8IDEyLjYgIHwgMzUuNiB8IDguOCAgICAgICB8IDIwLjYgICB8IDE2LjQgICB8IDMzLjQgfCA2LjggICAgfCA2LjY5ICAgICAgIHwgMTAuMiB8IDMuNSAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgIHwgICAgICAgICAgICAgICAgfCAwLjc4ICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwKfCDnvo7lm73vvIjkuIfkurrvvIkgfCAxMy45ICAgICAgIHwgNi4wICAgICAgICB8IDE1LjAgICAgIHwgNy4xICAgIHwgMS4yOSAgIHwgMi42ICAgfCA2LjcgICB8IDIuNyAgfCA4LjAgICAgICAgfCAyLjAgICAgfCAxLjQgICAgfCAzLjEgIHwgMi4wICAgIHwgNS42MyAgICAgICB8IDguMTYgfCAxMC4wICAgfCAgICAgICAgICAgICAgICB8IDE4MCAgICB8ICAgICAgICAgICAgICAgIHwgMC44NiAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8Cnwg5YWo55CD77yI5LiH5Lq677yJIHwgMTU4LjIgICAgICB8IDY4LjIgICAgICAgfCAxOTQuNiAgICB8IDc0LjUgICB8IDE4LjQgICB8IDM0LjYgIHwgNTEuNSAgfCA5MC4xIHwgNTUuMCAgICAgIHwgNDQuMCAgIHwgNzIuNSAgIHwgNzguNyB8IDMyLjUgICB8IDQ3ICAgICAgICAgfCA0MS4zIHwgMzUuNSAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8IDcuNzggICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfAp8IEvoja/ljZXoja8gfCAx57q/ICAgICAgICB8IFBELUwx4omlMSAgICB8IE1TSS1IL2RNTVIgfCBQRC1MMeKJpTEgfCAgICAgICAgfCAgICAgIHwgTVNJLUgvZE1NUiB8ICAgICAgICB8ICAgICAgICB8ICAgICAgIHwgICAgICAgIHwgICAgICAgfCAgICAgICAgfCAgICAgICAgICAgIHwgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8Cnwg5ZCO57q/ICAgIHwgUEQtTDHiiaUxICAgIHwgTVNJLUgvZE1NUiB8ICAgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICB8ICAgICAgICB8ICAgICAgfCAgICAgICAgfCAgICAgICAgfCBQRC1MMeKJpTEgfCAgICAgICB8ICAgICAgICB8IE1TSS1IL2RNTVIgfCAgICAgIHwgICAgICAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwKfCDlm7TmnK/mnJ8gIHwgICAgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgfCAgICAgICAgfCAgICAgIHwgICAgICAgIHwgICAgICAgfCAgICAgICAgfCAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgfCAgICAgIHwgICAgICAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwKfCBL6I2vK+WMlueWlyB8IDHnur8gICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICB8ICAgICAgICB8ICAgICAgfCBQRC1MMeKJpTEgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgIHwgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgfCAgICAgICAgfCAgICAgICAgICAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfAp8IOWQjue6vyAgICB8ICAgICAgICAgICAgfCAgICAgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgIHwgICAgICAgIHwgICAgICB8ICAgICAgICAgIHwgICAgICAgIHw=
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
所属报告:
康方生物-港股公司研究报告-全球双抗龙头依沃西引领二代IO新时代-250707(29页).pdf
打包全文图表
相关数据
ADC联合IO单抗治疗一线NSCLC全球三期研究启动时间
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
收藏
行业数据
2026-07-14
原图定位
查看详情
KRASG12C一线治疗NSCLC竞争格局(截至2026-6-25)
收藏
竞争格局
2026-07-01
原图定位
查看详情
全球KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
中国KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
ZG006临床2期研究的安全性数据(10mg剂量)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
ZG006临床2期研究的安全性数据(30mg剂量)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
SHR-A2009用于EGFR突变型NSCLC的1期临床研究结果
fCDmjIfmoIcgfCBPdmVyYWxsIChuPTQzKSB8IFByaW9yIFBCQyB0cmVhdGVkIChuPTI4KSB8IE92ZXJhbGwgKG49ODEpIHwgUHJpb3IgUEJDIHRyZWF0ZWQgKG49NDEpIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgRENSLCAlICg5NSUgQ0kpIHwgODMuNyAoNzMuNC05MS4wKSB8IDg2LjIgKDY5LjMtOTUuNSkgfCA4NS4yICg3NS41LTkyLjApIHwgODIuOSAoNjguOC05Mi41KSB8CnwgRE9SIHJhdGUgYXQgNiBtbywgJSAoOTUlIENJKSB8IDY3LjcgKDUxLjYtODAuNykgfCA1Mi4xICgzMS4xLTcyLjMpIHwgNjQuMyAoNDUuOC03OS43KSB8IDUyLjUgKDM1LjEtNjkuMikgfAp8IE1lZGlhbiBET1IgKDk1JSBDSSksIG1vIHwgOC41ICgzLjEtTlIpIHwgOC41ICgzLjAtTlIpIHwgNy4wICg0LjUtOC4yKSB8IDguNCAoMy4wLU5SKSB8CnwgT1JSLCAlICg5NSUgQ0kpIHwgNDYuNSAoMzIuMi02MS4zKSB8IDUwLjAgKDMwLjEtNjkuOSkgfCAzOC4zICgyOC44LTQ4LjMpIHwgMzkuMCAoMjQuMi01NS4xKSB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnlhazkvJflj7c=
收藏
行业数据
2026-05-28
原图定位
查看详情
SHR-A2009用于一线NSCLC患者的研究结果
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
收藏
行业数据
2026-05-28
原图定位
查看详情
2020-2034E中国非临床安全性评价市场规模(亿美元)
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
收藏
市场规模
2026-05-25
原图定位
查看详情
临床数据显示国产厂商有效性安全性比肩达芬奇
收藏
行业数据
2026-04-27
原图定位
查看详情
PD(L)1*VEGF双抗单药针对一线NSCLC数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
各药物针对IO耐药NSCLC临床数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
表2-7中国预制菜供应链安全性评估
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
收藏
自研数据
2026-03-04
原图定位
查看详情
表2-7中国精酿啤酒供应链安全性评估
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
收藏
自研数据
2026-03-02
原图定位
查看详情
表2-7中国精酿啤酒供应链安全性评估
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
收藏
自研数据
2026-03-02
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
差异化分子设计在安全性上有所体现。由于 Volrustomig 的研发公司阿斯利康在适应症上的规划与康方生物有所区别,因此我们选择了二者均有开展的非小细胞肺癌适应症的安全性数据进行对比。Volrustomig 的临床数据源于 2024 年 WCLC 会议上所披露的数据,其适应症为联用化疗治疗 NSCLC,安全性数据方面所有级别的 TRAE 发生率为97.1%,其中 3 级以上 TRAE 发生率高达 75.7%,并出现了 7 例治疗相关死亡。AK104所对比的临床数据源于 2025 年 AACR 会议上的披露,适应症同为联用化疗治疗 PD-L1阴性 NSCLC,其所有级别 TRAE 发生率为 80.3%,而 3 级以上 TRAE 发生率为 48.2%,明显低于 Volrustomig,且不存在治疗相关死亡。总体来看 AK104 在安全性上具有优势。
行业数据
原图定位
当前图表所属:
康方生物-港股公司研究报告-全球双抗龙头依沃西引领二代IO新时代-250707(29页).pdf
K药、AK112、AK104适应症布局梳理(绿色为获批,蓝色为III期,黄色为II期)
AK104销售预测(单位均为亿人民币)
AK104联用仑伐替尼+TACE治疗不可切除肝细胞癌的II期临床数据
AK104宫颈癌1L治疗注册临床安全性数据
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》